Hypoglycaemia News and Research

RSS
Lilly, Boehringer Ingelheim announce results from linagliptin Phase III trial on T2D

Lilly, Boehringer Ingelheim announce results from linagliptin Phase III trial on T2D

Lilly, Boehringer Ingelheim receive positive opinion from EMA for Jentadueto

Lilly, Boehringer Ingelheim receive positive opinion from EMA for Jentadueto

TAK-875 as effective as glimepiride in treating type 2 diabetes

TAK-875 as effective as glimepiride in treating type 2 diabetes

New drug improves glycaemic control with minimum risk of hypoglycemia in type 2 diabetics

New drug improves glycaemic control with minimum risk of hypoglycemia in type 2 diabetics

Series of studies on rising obesity rates among kids

Series of studies on rising obesity rates among kids

MT2 gene mutations may increase risk of diabetes

MT2 gene mutations may increase risk of diabetes

INT-777 shows promise against metabolic syndrome

INT-777 shows promise against metabolic syndrome

European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes

European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes

Scientists discover rare genetic alteration responsible for hypoglycaemia

Scientists discover rare genetic alteration responsible for hypoglycaemia

Lack of communication between diabetes patients and physicians around hypoglycaemia: Survey

Lack of communication between diabetes patients and physicians around hypoglycaemia: Survey

Novo Nordisk's insulin degludec reduces blood sugar in patients with type 2 diabetes

Novo Nordisk's insulin degludec reduces blood sugar in patients with type 2 diabetes

IQWiG publishes results of literature search on DMP for diabetes mellitus type 1

IQWiG publishes results of literature search on DMP for diabetes mellitus type 1

Living Cell Technologies xenoimplants first patients in Argentina trial

Living Cell Technologies xenoimplants first patients in Argentina trial

Intensive glycaemic control may negatively affect a person's quality of life

Intensive glycaemic control may negatively affect a person's quality of life

Channel Swim Relay event aims to raise money for JDRF

Channel Swim Relay event aims to raise money for JDRF

Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes

Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Diabetes cell implant company approved for Argentina clinical trial

Diabetes cell implant company approved for Argentina clinical trial

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Leading foundations support Australian diabetes treatment

Leading foundations support Australian diabetes treatment